Filed: 2/14/2024ACC: 0001172661-24-001530
π What this filing means
TWIN SECURITIES, INC. filed this quarterly 13FβHR report disclosing 8 equity positions with a total reported market value of $94.80M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
8
Positions
$94.80M
Total AUM (reported)
1.52M
Total Shares
Allocation by class
COM$85.87M90.6%
CL A COM$8.93M9.4%
Portfolio Concentration
Top 3$62.70M66.1%
4β10$32.10M33.9%
Top 3 weight
66.1%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 1.52M
Sole
Full voting authority
1.52M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole8
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings8
Rows:
KARUNA THERAPEUTICS INC
SOLEShares127.31K
TypeSH
Market value$40.29M
42.50%
Sole
127.31K
Shared
0.00
None
0.00
UNITED STATES STL CORP NEW
SOLEShares257.73K
TypeSH
Market value$12.54M
13.23%
Sole
257.73K
Shared
0.00
None
0.00
CEREVEL THERAPEUTICS HLDNG I
SOLEShares232.71K
TypeSH
Market value$9.87M
10.41%
Sole
232.71K
Shared
0.00
None
0.00
SPLUNK INC
SOLEShares59.65K
TypeSH
Market value$9.09M
9.59%
Sole
59.65K
Shared
0.00
None
0.00
ENDEAVOR GROUP HLDGS INC
SOLEShares376.47K
TypeSH
Market value$8.93M
9.42%
Sole
376.47K
Shared
0.00
None
0.00
IMMUNOGEN INC
SOLEShares221.62K
TypeSH
Market value$6.57M
6.93%
Sole
221.62K
Shared
0.00
None
0.00
KENVUE INC
SOLEShares228.70K
TypeSH
Market value$4.92M
5.19%
Sole
228.70K
Shared
0.00
None
0.00
PIONEER NAT RES CO
SOLEShares11.50K
TypeSH
Market value$2.59M
2.73%
Sole
11.50K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting β Sole | Shared | None |
|---|---|---|---|---|---|---|---|
KARUNA THERAPEUTICS INCSOLE | COM | 127.31K | SH | $40.29M 42.50% | 127.31K | 0.00 | 0.00 |
UNITED STATES STL CORP NEWSOLE | COM | 257.73K | SH | $12.54M 13.23% | 257.73K | 0.00 | 0.00 |
CEREVEL THERAPEUTICS HLDNG ISOLE | COM | 232.71K | SH | $9.87M 10.41% | 232.71K | 0.00 | 0.00 |
SPLUNK INCSOLE | COM | 59.65K | SH | $9.09M 9.59% | 59.65K | 0.00 | 0.00 |
ENDEAVOR GROUP HLDGS INCSOLE | CL A COM | 376.47K | SH | $8.93M 9.42% | 376.47K | 0.00 | 0.00 |
IMMUNOGEN INCSOLE | COM | 221.62K | SH | $6.57M 6.93% | 221.62K | 0.00 | 0.00 |
KENVUE INCSOLE | COM | 228.70K | SH | $4.92M 5.19% | 228.70K | 0.00 | 0.00 |
PIONEER NAT RES COSOLE | COM | 11.50K | SH | $2.59M 2.73% | 11.50K | 0.00 | 0.00 |